 CRANFORD, N.J., April 22, 2021 PRNewswire -- Citius Pharmaceuticals, Inc. Citius or the Company Nasdaq: CTXR, a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that Citius President and CEO, Myron Holubiak, was featured in an interview with Benzinga discussing the Companys product pipeline, the impact of Covid-19, and upcoming milestones. 